BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28814605)

  • 1. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
    Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
    J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell ADAM10 Controls Murine Lupus Progression through Regulation of the ICOS:ICOS Ligand Axis.
    Lownik JC; Wimberly JL; Conrad DH; Martin RK
    J Immunol; 2019 Feb; 202(3):664-674. PubMed ID: 30610163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility.
    Xu H; Li X; Liu D; Li J; Zhang X; Chen X; Hou S; Peng L; Xu C; Liu W; Zhang L; Qi H
    Nature; 2013 Apr; 496(7446):523-7. PubMed ID: 23619696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
    Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
    J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice.
    Wang B; Liang S; Wang Y; Zhu XQ; Gong W; Zhang HQ; Li Y; Xia CM
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003434. PubMed ID: 25590646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease.
    Uwadiae FI; Pyle CJ; Walker SA; Lloyd CM; Harker JA
    Allergy; 2019 Apr; 74(4):650-662. PubMed ID: 30220084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
    Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production.
    Damle SR; Martin RK; Cockburn CL; Lownik JC; Carlyon JA; Smith AD; Conrad DH
    Allergy; 2018 Jan; 73(1):125-136. PubMed ID: 28745029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
    Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
    Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
    Folgosa L; Zellner HB; El Shikh ME; Conrad DH
    J Immunol; 2013 Dec; 191(12):5951-8. PubMed ID: 24227779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
    Carrell RK; Stanton RA; Ethier SP; LaRue AC; Soloff AC
    Vaccine; 2018 Oct; 36(42):6262-6269. PubMed ID: 30219366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction.
    Liu D; Xu H; Shih C; Wan Z; Ma X; Ma W; Luo D; Qi H
    Nature; 2015 Jan; 517(7533):214-8. PubMed ID: 25317561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic alteration of CD154/CD40 and its effects on Th1/Th2 polarization in inducible co-stimulator ligand knockout mice infected with Schistosoma japonicum].
    Wang Y; Xia CM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):898-904. PubMed ID: 26679647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.
    Teichmann LL; Cullen JL; Kashgarian M; Dong C; Craft J; Shlomchik MJ
    Immunity; 2015 Mar; 42(3):552-65. PubMed ID: 25786178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
    Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
    Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.